PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Cedars-Sinai Cancer, Los Angeles, California, USA.\', \'Department of Research, Greater Los Angeles Veterans Administration, Los Angeles, California, USA.\', \'Department of Infectious Diseases, Cedars-Sinai Medical Center, Los Angeles, California.\', \'Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.\', \'Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah.\', \'Department of Surgery, Cedars-Sinai Cancer, Los Angeles, California.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1530/ERC-20-0165ERC-20-0165
?:hasPublicationType
?:journal
  • Endocrine-related cancer
is ?:pmid of
?:pmid
?:pmid
  • 32508311
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.118
?:rankingScore_hIndex
  • 115
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and androgen-targeted therapy for prostate cancer patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all